Full name
SOLVEMED GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
62.09.Z - Activities related to programming, IT consulting, and related activities
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -2,4 | -8 | -8,3 | -4,3 |
EBITDA | -8 | -7,7 | 4,2 | |
Short time liabilities | 0,9 | 0,2 | -80,3 | |
Income tax | 0 | 0 | ||
Equity capital | -0,4 | 7,2 | 3,2 | -54,9 |
Operating profit (EBIT) | -8 | -7,7 | 4,1 | |
Assets | 0,7 | 8,3 | 3,4 | -58,5 |
Net profit (loss) | -2,4 | -8 | -8,3 | -4,3 |
Cash | 7 | 2,5 | -64,4 | |
Net income from sale | 0 | 0 | -∞ | |
Liabilities and provisions for liabilities | 1,1 | 1,1 | 0,2 | -82,4 |
Working assets | 0,6 | 8,2 | 3,3 | -59,2 |
Depreciation | 0 | 0 | 32,1 | |
Basic operational activity income | 0 | 0 | ||
% | % | % | p.p. | |
Profitability of capital | -110,7 | -255,9 | -145,2 | |
Equity capital to total assets | -55,4 | 86,9 | 94,5 | 7,6 |
Gross profit margin | -185 862,2 | |||
EBITDA Margin | -172 112,5 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 15 273 | -2 147 468 375 | |
Net dept to EBITDA | 0.8738881945610046 | 0.32404738664627075 | -0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane